<?xml version="1.0" encoding="UTF-8"?>
<ref id="B296-pharmaceuticals-12-00147">
 <label>296.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Oberley-Deegan</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Nikrad</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Funk</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Hartshorn</surname>
    <given-names>K.L.</given-names>
   </name>
   <name>
    <surname>Mason</surname>
    <given-names>R.J.</given-names>
   </name>
  </person-group>
  <article-title>Differentiated Human Alveolar Type II Cells Secrete Antiviral IL-29 (IFN-Î»1) in Response to Influenza A Infection</article-title>
  <source>J. Immunol.</source>
  <year>2009</year>
  <volume>182</volume>
  <fpage>1296</fpage>
  <lpage>1304</lpage>
  <pub-id pub-id-type="doi">10.4049/jimmunol.182.3.1296</pub-id>
  <pub-id pub-id-type="pmid">19155475</pub-id>
 </element-citation>
</ref>
